Hantz Financial Services, Inc. Novo Nordisk A S Transaction History

Hantz Financial Services, Inc.

  • $6.6 Billion
  • Q3 2025

A detailed history of Hantz Financial Services, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 57,426 shares of NVO stock, worth $2.78 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
57,426
Previous 79,542 27.8%
Holding current value
$2.78 Million
Previous $5.49 Million 41.95%
% of portfolio
0.05%
Previous 0.09%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025
SELL
$45.38 - $71.7 $1 Million - $1.59 Million
-22,116 Reduced 27.8%
57,426 $3.19 Million
Q2 2025

Aug 04, 2025
SELL
$58.08 - $81.05 $1.01 Million - $1.41 Million
-17,393 Reduced 17.94%
79,542 $5.49 Million
Q1 2025

May 12, 2025
SELL
$69.3 - $90.95 $6.09 Million - $8 Million
-87,944 Reduced 47.57%
96,935 $6.73 Million
Q4 2024

Jan 23, 2025
BUY
$85.0 - $120.04 $178,840 - $252,564
2,104 Added 1.15%
184,879 $15.9 Million
Q3 2024

Nov 13, 2024
SELL
$119.07 - $145.42 $263,382 - $321,669
-2,212 Reduced 1.2%
182,775 $21.8 Million
Q2 2024

Jul 30, 2024
BUY
$122.71 - $146.91 $22.7 Million - $27.2 Million
184,987 New
184,987 $26.4 Million
Q1 2024

Aug 06, 2024
SELL
$102.11 - $135.92 $886,723 - $1.18 Million
-8,684 Reduced 4.93%
167,378 $21.5 Million
Q4 2023

Aug 06, 2024
BUY
$87.78 - $105.45 $6.17 Million - $7.41 Million
70,259 Added 66.41%
176,062 $18.2 Million
Q3 2023

Aug 06, 2024
BUY
$90.94 - $199.54 $8.38 Million - $18.4 Million
92,140 Added 674.38%
105,803 $9.62 Million
Q2 2023

Aug 06, 2024
BUY
$155.98 - $172.65 $35,407 - $39,191
227 Added 1.69%
13,663 $2.21 Million
Q1 2023

Aug 06, 2024
BUY
$132.34 - $159.14 $304,249 - $365,862
2,299 Added 20.64%
13,436 $2.14 Million
Q4 2022

Aug 06, 2024
BUY
$102.55 - $135.33 $155,773 - $205,566
1,519 Added 15.79%
11,137 $1.51 Million
Q3 2022

Aug 06, 2024
BUY
$95.28 - $116.93 $662,100 - $812,546
6,949 Added 260.36%
9,618 $958,000
Q2 2022

Aug 06, 2024
BUY
$103.24 - $121.81 $7,330 - $8,648
71 Added 2.73%
2,669 $297,000
Q3 2021

Aug 06, 2024
BUY
$84.42 - $106.62 $590 - $746
7 Added 0.27%
2,598 $249,000
Q2 2021

Aug 06, 2024
BUY
$67.66 - $84.76 $1,353 - $1,695
20 Added 0.78%
2,591 $217,000
Q1 2021

Aug 06, 2024
SELL
$67.06 - $75.82 $12.2 Million - $13.8 Million
-182,416 Reduced 98.61%
2,571 $173,000
Q4 2020

Aug 06, 2024
SELL
$63.89 - $73.8 $11.6 Million - $13.4 Million
-182,010 Reduced 98.39%
2,977 $208,000

Others Institutions Holding NVO

# of Institutions
1,686
Shares Held
304M
Call Options Held
25.9M
Put Options Held
43.8M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email